Cargando…

Eliminating Race From eGFR Calculations: Impact on Living Donor Programs

Detalles Bibliográficos
Autores principales:	Bellini, Maria Irene, Nozdrin, Mikhail, Naesens, Maarten, Martins, Paulo N.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Health Archive
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9691657/ https://www.ncbi.nlm.nih.gov/pubmed/36438782 http://dx.doi.org/10.3389/ti.2022.10787

Ejemplares similares

External Validation of Toulouse-Rangueil eGFR12 Prediction Model After Living Donor Nephrectomy
por: Patel, Suhani S., et al.
Publicado: (2023)

GFR Estimation in Potential Living Kidney Donors: Race- and Nonrace-based Equations and Measured GFR
por: Goodson, David Alex, et al.
Publicado: (2022)

Editorial: Transplant International Goes for GOLD!
por: Bellini, Maria Irene, et al.
Publicado: (2022)

Editorial: Rubies for ESOT!
por: Berney, Thierry, et al.
Publicado: (2022)

Reflecting on an Intense Year for Transplant International
por: Berney, Thierry, et al.
Publicado: (2022)

Risks for donors associated with living kidney donation: meta-analysis( )
por: Bellini, Maria Irene, et al.
Publicado: (2022)

How good is a living donor? Systematic review and meta-analysis of the effect of donor demographics on post kidney transplant outcomes
por: Bellini, Maria Irene, et al.
Publicado: (2022)

282 Preoperative Assessment of GFR With Race-Based Versus Non-Race-Based GFR Calculators Prior to Nephrectomy for Renal Carcinoma
Publicado: (2022)

Embracing the Wisdom of Ancient Greece in the Era of Personalized Medicine—Uncertainty, Probabilistic Reasoning, and Democratic Consensus
por: Naesens, Maarten
Publicado: (2023)

The Impact of Recipient Demographics on Outcomes from Living Donor Kidneys: Systematic Review and Meta-Analysis †
por: Bellini, Maria Irene, et al.
Publicado: (2021)

Ipsilateral Aorto-Iliac Calcification is Not Directly Associated With eGFR After Kidney Transplantation: A Prospective Cohort Study Analyzed Using a Linear Mixed Model
por: Rijkse, Elsaline, et al.
Publicado: (2023)

Patient-Reported Outcomes as Endpoints in Clinical Trials of Kidney Transplantation Interventions
por: Tong, Allison, et al.
Publicado: (2022)

Redefining Risk Stratification and Endpoints for Clinical Trials in Kidney Transplantation: Rationale and Methodology of Proposals Submitted to the European Medicines Agency by the European Society for Organ Transplantation
por: Naesens, Maarten, et al.
Publicado: (2022)

Clinical Assessment of Follow-Up Cystatin C-Based eGFR in Live Kidney Donors
por: Han, Hyun Ho, et al.
Publicado: (2012)

External Validation of the Toulouse-Rangueil Predictive Model to Estimate Donor Renal Function After Living Donor Nephrectomy
por: Almeida, Manuela, et al.
Publicado: (2023)

Is Bigger Better? Living Donor Kidney Volume as Measured by the Donor CT Angiogram in Predicting Donor and Recipient eGFR after Living Donor Kidney Transplantation
por: Ebad, Chaudhry Adeel, et al.
Publicado: (2021)

Performance of the race-free CKD-EPI creatinine-based eGFR equation in a Danish cohort with measured GFR
por: Munch, Philip Vestergaard, et al.
Publicado: (2023)

Xenotransplantion: Defeating the “Shumway Curse” An Interview With Drs. Bartley Griffith, Jayme Locke, Robert Montgomery, and Bruno Reichart
por: Berney, Thierry, et al.
Publicado: (2022)

Rationale for Surrogate Endpoints and Conditional Marketing Authorization of New Therapies for Kidney Transplantation
por: Naesens, Maarten, et al.
Publicado: (2022)

Surrogate Endpoints for Late Kidney Transplantation Failure
por: Naesens, Maarten, et al.
Publicado: (2022)

The Role of Fc Gamma Receptors in Antibody-Mediated Rejection of Kidney Transplants
por: Delpire, Boris, et al.
Publicado: (2022)

Improved estimation of glomerular filtration rate (GFR) by comparison of eGFR(cystatin C) and eGFR(creatinine)
por: Grubb, Anders, et al.
Publicado: (2012)

Living Donor Kidney Transplant in Recipients With Glomerulonephritis: Donor Recipient Biologic Relationship and Allograft Outcomes
por: El-Rifai, Rasha, et al.
Publicado: (2023)

Allograft Function as Endpoint for Clinical Trials in Kidney Transplantation
por: Hilbrands, Luuk, et al.
Publicado: (2022)

Alloimmune Risk Stratification for Kidney Transplant Rejection
por: Bestard, Oriol, et al.
Publicado: (2022)

Relinquishing Anonymity in Living Donor Kidney Transplantation: Lessons Learned From the UK Policy for Anonymous Donors
por: Pronk, Mathilde C., et al.
Publicado: (2022)

Estimation of Donor Renal Function After Living Donor Nephrectomy: The Value of the Toulouse-Rangueil Predictive Model
por: Prudhomme, Thomas, et al.
Publicado: (2023)

The Clinical Utility of Post-Transplant Monitoring of Donor-Specific Antibodies in Stable Renal Transplant Recipients: A Consensus Report With Guideline Statements for Clinical Practice
por: van den Broek, Dennis A. J., et al.
Publicado: (2023)

Proposed Definitions of T Cell-Mediated Rejection and Tubulointerstitial Inflammation as Clinical Trial Endpoints in Kidney Transplantation
por: Seron, Daniel, et al.
Publicado: (2022)

Proposed Definitions of Antibody-Mediated Rejection for Use as a Clinical Trial Endpoint in Kidney Transplantation
por: Roufosse, Candice, et al.
Publicado: (2022)

Evolution of the Definition of Rejection in Kidney Transplantation and Its Use as an Endpoint in Clinical Trials
por: Becker, Jan Ulrich, et al.
Publicado: (2022)

Considering ABO Incompatible Living Donor Kidney Transplantation Before Deceased Donor Kidney Transplantation in Children: A Letter to the Editor
por: Paessler, Alicia, et al.
Publicado: (2023)

The Case Against Race-Based GFR
por: Uppal, Prabhdeep, et al.
Publicado: (2022)

Donor Skeletal Muscle Quality Affects Graft Mortality After Living Donor Liver Transplantation- A Single Center, Retrospective Study
por: Tomiyama, Takahiro, et al.
Publicado: (2022)

ABO-Incompatibility: Time to Challenge the Paradigm of Equivalence in Live-Donor Kidney Transplantation?
por: Eskandary, Farsad, et al.
Publicado: (2022)

Long-Term Kidney and Maternal Outcomes After Pregnancy in Living Kidney Donors
por: van Buren, Marleen C., et al.
Publicado: (2023)

Editorial: Equity in Transplantation: A Commitment for Progress in Troubled Times
por: Berney, Thierry, et al.
Publicado: (2022)

Hepatolithiasis After Living Donor Liver Transplantation in Pediatric Patients: Mechanism, Diagnosis, Treatment, and Prognosis
por: Sanada, Yukihiro, et al.
Publicado: (2022)

European Guideline for the Management of Kidney Transplant Patients With HLA Antibodies: By the European Society for Organ Transplantation Working Group
por: Mamode, Nizam, et al.
Publicado: (2022)

Creating a Single Inflow Orifice From Living Donor Kidney Allografts With Multiple Renal Arteries
por: Tabbara, Marina M., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_2h0su5nb00t42u6k2nn6mh5vfa